Cargando…

Comparison between the pharmacokinetics of meranzin hydrate in a rat model of chronic depression and in controls following the oral administration of Chaihu-Shugan-San

Previous studies have shown that meranzin hydrate (MH) may be beneficial in depressive disorders. However, to the best of our knowledge, the pharmacokinetic characteristics of MH in depression have not previously been investigated. Chronic mild stress (CMS) in rats is used as a model of depression....

Descripción completa

Detalles Bibliográficos
Autores principales:	XIE, WEIBIN, QIU, XINJIAN, HUANG, XI, XIE, YING, WU, KAIGE, WANG, YANG, JI, HUI, HE, JUAN, REN, PING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797319/ https://www.ncbi.nlm.nih.gov/pubmed/24137289 http://dx.doi.org/10.3892/etm.2013.1229

Ejemplares similares

Searching the Cytochrome P450 Enzymes for the Metabolism of Meranzin Hydrate: A Prospective Antidepressant Originating from Chaihu-Shugan-San
por: Huang, Xi, et al.
Publicado: (2014)

Chaihu-Shugan-San Administration Ameliorates Perimenopausal Anxiety and Depression in Rats
por: Chen, Shujiao, et al.
Publicado: (2013)

Simultaneous Determination of Five Components of Chaihu-Shugan-San in Beagle Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study after a Single Dose of Chaihu-Shugan-San
por: Zhu, Yong-liang, et al.
Publicado: (2020)

Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression
por: Qiu, Juan, et al.
Publicado: (2014)

Antidepressant-like effects of Chaihu-Shugan-San via SAPK/JNK signal transduction in rat models of depression
por: Li, Yun-Hui, et al.
Publicado: (2014)

Meranzin hydrate from Muraya paniculata
por: Julaeha, Euis, et al.
Publicado: (2010)

Antidepressant-like activity of Chaihu-Shugan-San aqueous extract in rats and its possible mechanism
por: Wang, Sue, et al.
Publicado: (2014)

Exploring mechanisms of Chaihu-Shugan-San against liver fibrosis by integrated multi-omics and network pharmacology approach
por: Xie, Zhihao, et al.
Publicado: (2022)

Reporting quality and risk of bias assessment of animal research on Chaihu-Shugan-San for depression: A systematic review
por: Zhu, Xiao, et al.
Publicado: (2023)

Potential Molecular Mechanisms of Chaihu-Shugan-San in Treatment of Breast Cancer Based on Network Pharmacology
por: Xiao, Kunmin, et al.
Publicado: (2020)

Effects of Chaihu-Shugan-San for reflux esophagitis: A protocol for systematic review and meta-analysis
por: Zhou, Yan, et al.
Publicado: (2020)

Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression via modulating sphingolipid and glycerinphospholipid metabolism
por: Li, Wei, et al.
Publicado: (2022)

SIRT1/FOXO1 Axis-Mediated Hippocampal Angiogenesis is Involved in the Antidepressant Effect of Chaihu Shugan San
por: Zhang, Shan, et al.
Publicado: (2022)

Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex
por: Yan, Lijing, et al.
Publicado: (2020)

Ethnopharmacokinetic- and Activity-Guided Isolation of a New Antidepressive Compound from Fructus Aurantii Found in the Traditional Chinese Medicine Chaihu-Shugan-San: A New Approach and Its Application
por: Fan, Rong, et al.
Publicado: (2012)

Effects of Chaihu-Shugan-San capsule for psychogenic erectile dysfunction: Study protocol of a randomized placebo-controlled trial
por: Ren, Feiqiang, et al.
Publicado: (2019)

Chaihu-shugan-san alleviates depression-like behavior in mice exposed to chronic unpredictable stress by altering the gut microbiota and levels of the bile acids hyocholic acid and 7-ketoDCA
por: Ma, Chong, et al.
Publicado: (2022)

Effects of Chaihu-Shugan-San and Shen-Ling-Bai-Zhu-San on p38 MAPK Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis
por: Yang, Qin-He, et al.
Publicado: (2014)

Chaihu Shugan San promotes gastric motility in rats with functional dyspepsia by regulating Drp-1-mediated ICC mitophagy
por: Li, Li, et al.
Publicado: (2023)

Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8
por: Li, Zhiyue, et al.
Publicado: (2023)

A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview
por: Gao, Zu, et al.
Publicado: (2022)

Effect of Chaihu-Shugan-San on the mRNA expression of the 5-HT1A receptor and cellular proliferation in the hippocampus of epileptic rats with depression
por: YANG, PING, et al.
Publicado: (2016)

Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress
por: Zhu, Xiaofei, et al.
Publicado: (2022)

Modified Chaihu Shugan Powder for Functional Dyspepsia: Meta-Analysis for Randomized Controlled Trial
por: Yang, Nan, et al.
Publicado: (2013)

Effect of Chaihu Shugan Pills on the Pharmacokinetics of Duloxetine and its Metabolite 4-Hydroxyduloxetine in Beagle Dogs: A Herb-Drug Interaction Study
por: Bi, Yun-tian, et al.
Publicado: (2022)

Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
por: Zhang, Shan, et al.
Publicado: (2021)

Chaihu-Shugan-San Reinforces CYP3A4 Expression via Pregnane X Receptor in Depressive Treatment of Liver-Qi Stagnation Syndrome
por: He, Zehui, et al.
Publicado: (2019)

Comparative Pharmacokinetics of Naringin in Rat after Oral Administration of Chaihu-Shu-Gan-San Aqueous Extract and Naringin Alone
por: Li, Shu-Qi, et al.
Publicado: (2013)

Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways
por: Liu, Qiong, et al.
Publicado: (2018)

Chaihu-Shugan-San (Shihosogansan) alleviates restraint stress-generated anxiety and depression in mice by regulating NF-κB-mediated BDNF expression through the modulation of gut microbiota
por: Han, Sang-Kap, et al.
Publicado: (2021)

Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway
por: Liang, Yinji, et al.
Publicado: (2018)

Effect of Chaihu Shugan Powder-Contained Serum on Glutamate-Induced Autophagy of Interstitial Cells of Cajal in the Rat Gastric Antrum
por: Tan, Ren-Qian, et al.
Publicado: (2019)

Network pharmacology and experimental studies for deciphering the molecular targets and mechanisms of Chaihu Shugan powder in the treatment of functional dyspepsia
por: Wang, Yujiao, et al.
Publicado: (2023)

A Prospective Study of Using Chaihu Shugan Powder Combined with Zu San Li Acupoint Stimulation to Improve the Prognosis of Liver Stagnation and Qi Stagnation Syndrome in Acute Pancreatitis
por: Lu, Wei-Wei, et al.
Publicado: (2022)

Retracted: A Prospective Study of Using Chaihu Shugan Powder Combined with Zu San Li Acupoint Stimulation to Improve the Prognosis of Liver Stagnation and Qi Stagnation Syndrome in Acute Pancreatitis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

A network pharmacology‐based approach to explore the effects of Chaihu Shugan powder on a non‐alcoholic fatty liver rat model through nuclear receptors
por: Nie, Huan, et al.
Publicado: (2020)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
por: Lei, Sisi, et al.
Publicado: (2022)

Gut Microbiota Is the Key to the Antidepressant Effect of Chaihu-Shu-Gan-San
por: Yu, Meng, et al.
Publicado: (2020)

Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems
por: Zhang, Meng, et al.
Publicado: (2022)

Meta-analysis of Shugan Jieyu Capsule for depression in patients with coronary heart disease
por: Liu, Zhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ipk645b8n0mphdv1ern3f92o8q